148 studies found for:    "Hemangioma"
Show Display Options
Rank Status Study
1 Unknown  Topical Timolol Gel for the Treatment of Infantile Hemangiomas
Condition: Hemangioma
Interventions: Drug: timolol maleate 0.5% gel;   Drug: Placebo vehicle/solution
2 Completed A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy
Condition: Hemangioma, Capillary
Intervention: Drug: Imiquimod 5% cream
3 Completed Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma
Condition: Hemangioma
Interventions: Drug: Propranolol;   Drug: Prednisone
4 Withdrawn Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)
Condition: Infantile Hemangiomas
Interventions: Drug: Timolol 0.5% Gel Forming Solution (GFS);   Drug: Mupirocin 2% Ointment
5 Completed
Has Results
Hemangioma Associated With High Rates of Morbidity
Condition: Hemangioma
Interventions: Device: MRI;   Device: MRI of head and neck;   Other: Dermatological Examination;   Other: Cardiac examination;   Device: Abdominal ultrasound
6 Terminated Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma
Condition: Hemangioma
Interventions: Drug: Acebutolol;   Drug: Propanolol
7 Unknown  Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas
Conditions: Hemangioma;   Infant
Interventions: Drug: topical 0.5% Timolol;   Drug: Control (placebo) group
8 Recruiting Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma
Condition: Hemangioma
Interventions: Drug: Propranolol;   Drug: Atenolol
9 Terminated Propranolol in Capillary Hemangiomas
Condition: Hemangioma, Capillary
Interventions: Drug: propranolol treatment;   Drug: placebo treatment
10 Active, not recruiting Optical Tomographic Imaging of Infantile Hemangiomas
Condition: Infantile Hemangioma
Intervention:
11 Active, not recruiting Genetic Basis of Hemangiomas
Condition: Hemangioma, Vascular Anomalies
Interventions: Genetic: Cheek cell samples or blood sample (4mL);   Genetic: Cheek cell sample or blood sample (4mL)
12 Completed Nadolol for Proliferating Infantile Hemangiomas
Condition: Infantile Hemangioma
Intervention: Drug: Nadolol
13 Completed Ontogeny of Infantile Hemangiomas With Skin Imaging Modalities
Condition: Infantile Hemangiomas
Intervention:
14 Recruiting A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
Condition: Hemangioma
Interventions: Drug: topical timolol maleate;   Device: Pulsed dye laser
15 Completed Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo
Condition: Infantile Hemangioma
Interventions: Drug: propranolol gel;   Drug: Placebo
16 Recruiting Nadolol Versus Propranolol in Children With Infantile Hemangiomas
Condition: Infantile Hemangioma
Interventions: Drug: Nadolol;   Drug: Propranolol
17 Terminated Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)
Conditions: Infantile Hemangioma;   Very Low Birth Weight Infants
Interventions: Drug: topical 0.5% Timolol maleate;   Drug: Control (placebo) group
18 Completed Hemangioma Growth During the First 6 Months of Life
Condition: Hemangiomas of Infancy
Intervention: Other: No intervention
19 Completed Diagnosis of Hemangiomas and Vascular Malformations
Conditions: Hemangiomas;   Vascular Malformations;   Venular Malformations;   Venous Malformations;   Lymphatic Malformations;   Arteriovenous Malformations
Intervention:
20 Completed
Has Results
Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy
Condition: Infantile Hemangioma
Interventions: Drug: Propranolol;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years